Assessment of coronary heart disease risk by combined analysis of coagulation factors

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 294-300

  Aleksic, Nena ^a   Wang, Yao Wei W ^a   Ahn, Chul ^a   Juneja, Harinder S ^a   Folsom, Aaron R ^b   Wu, Kenneth K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Coronary heart disease; Factor VIII; Fibrinogen; PAI 1; Soluble thrombomodulin

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN INTERACTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 44149116748     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.062     Document Type: Article

References (30)

1. K.K. Wu N. Matijevic-Aleksic Molecular aspects of thrombosis and antithrombotic drugs Crit Rev Clin Lab Sci 42 2005 249 277
2. L. Bajzar M. Nesheim J. Morser P.B. Tracy Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor J Biol Chem 273 1998 2792 2798
3. K.K. Wu N. Matijevic-Aleksic Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis Ann Med 32 Suppl. 1 2000 73 77
4. L.O. Mosnier J.C.M. Meijers B.N. Bouma Regulation of fibrinolysis in plasma by TAFI and Protein C is dependent on the concentration of thrombomodulin Thromb Haemost 85 2001 5 11
5. L.A. Robbie B. Bennett A.M. Croll P.A. Brown N.A. Booth Proteins of the fibrinolytic system in human thrombi Thromb Haemost 75 1996 127 133
6. L. Wilhelmsen K. Svardsudd K. Korsan-Bengtsen Fibrinogen as a risk factor for stroke and myocardial infarction N Engl J Med 311 1984 501 505
7. T.W. Meade S. Mellows M. Brozovic Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study Lancet 2 1986 533 537
8. W.B. Kannel P.A. Wolf W.P. Castelli R.B. D’Agostino Fibrinogen and risk of cardiovascular disease. The Framingham Study JAMA 258 1987 1183 1186
9. A.R. Folsom K.K. Wu W.D. Rosamond A.R. Sharrett L.E. Chambless Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study Circulation 96 1997 1102 1108
10. V. Salomaa C. Matei N. Aleksic Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study Lancet 353 1999 1729 1734
11. S.G. Thompson J. Kienast S.D. Pyke F. Haverkate J.C. van de Loo Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group N Engl J Med 332 1995 635 641
12. A.R. Folsom N. Aleksic E. Park Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study Arterioscler Thromb Vasc Biol 21 2001 611 617
13. K.K. Wu N. Aleksic C.M. Ballantyne Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease Circulation 107 2003 1729 1732
14. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687–702.
15. A.D. White A.R. Folsom L.E. Chambless Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years’ experience J Clin Epidemiol 49 1996 223 233
16. W.D. Rosamond L.E. Chambless A.R. Folsom Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994 N Engl J Med 339 1998 861 867
17. N. Aleksic H. Juneja A.R. Folsom Platelet PLA2 allele and incidence of coronary heart disease. Results from the ARIC study Circulation 102 2000 1901 1905
18. A.C. Papp H. Hatzakis A. Bracey K.K. Wu ARIC hemostasis study. I. Development of a blood collection and processing system suitable for multicenter hemostatic studies Thromb Haemost 61 1989 15 59
19. K.K. Wu A.C. Papp W. Patsch ARIC hemostasis study. II. Organizational plan and feasibility study Thromb Haemost 64 1990 521 525
20. A.R. Folsom N. Aleksic D. Catellier H.S. Juneja K.K. Wu C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study Am Heart J 244 2002 233 238
21. K.K. Wu A.R. Folsom G. Heiss Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study Ann Epidemiol 2 1992 471 480
22. R.L. Prentice A case-cohort design for epidemiological cohort studies and disease prevention risk Biometrika 73 1986 1
23. W.E. Barlow Robust variance estimation for the case-cohort design Biometrics 50 1994 1064 1072
24. C.T. Esmon Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface FASEB J 9 1995 946 955
25. A. Leone Smoking, haemostatic factors, and cardiovascular risk Curr Pharm Des 13 16 2007 1661 1667
26. J.A. Fernández A. Gruber M.J. Heeb J.H. Griffin Protein C pathway impairment in nonsymptomatic cigarette smokers Blood Cells Mol Dis 29 2002 73 82
27. W.E. Stites J.W. Froude II Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics? Med Hypotheses 68 2007 811 821
28. V.A. Van Hylckama P.W. Callas M. Cushman R.M. Bertina F.R. Rosendaal Inter-relation of coagulation factors and D-dimer levels in healthy individuals J Thromb Haemost 1 2003 516 522
29. N.J. Mutch L. Thomas N.R. Moore K.M. Lisiak N.A. Booth TAFIa, PAI-1 and α2-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots J Thromb Haemost 5 2007 812 817
30. A.D. Blann J. Amiral C.N. McCollum Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischemic heart disease Eur J Haematol 59 1997 115 120